ENTADFI is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Veru Inc.. The primary component is Tadalafil; Finasteride.
| Product ID | 69681-125_3a043550-4704-4da9-a3d4-24c198ca7bf6 |
| NDC | 69681-125 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ENTADFI |
| Generic Name | Finasteride And Tadalafil |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-12-12 |
| Marketing Category | NDA / |
| Application Number | NDA215423 |
| Labeler Name | Veru Inc. |
| Substance Name | TADALAFIL; FINASTERIDE |
| Active Ingredient Strength | 5 mg/1; mg/1 |
| Pharm Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA],5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-12-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ENTADFI 90882046 not registered Live/Pending |
Veru Inc. 2021-08-13 |
![]() ENTADFI 90830745 not registered Live/Pending |
Veru Inc. 2021-07-15 |